GlassScriptPhysician profile
Madison Hill
NPI 1811474133
$1,298.43
in general payments reported to CMS, 2019-2025
16 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.36 · 2023: $673 · 2024: $356 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $281.17 | 2023 | Xarelto |
| Lilly USA, LLC | $193.11 | 2021-2025 | Mounjaro, Zepbound |
| Amgen INC. | $120.61 | 2024-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $108.09 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $95.35 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.98 | 2023-2025 | |
| Novo Nordisk INC | $65.83 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $55.52 | 2021-2023 | |
| Exact Sciences Corporation | $47.73 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $47.43 | 2023-2024 | Veozah |
| Astrazeneca Pharmaceuticals LP | $45.32 | 2024-2025 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.61 | 2023-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $34.40 | 2024 | Eliquis |
| Evoke Pharma, INC. | $34.19 | 2023-2024 | Gimoti |
| Janssen Biotech, INC. | $28.80 | 2025 | Tremfya |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.29 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.